Clinical Trials Logo

Cesarean Delivery clinical trials

View clinical trials related to Cesarean Delivery.

Filter by:

NCT ID: NCT03335436 Withdrawn - Pain Management Clinical Trials

Gabapentin in the Post-cesarean Pain Management of Buprenorphine Patient

Start date: April 1, 2018
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine whether a perioperative course of gabapentin in parturients on buprenorphine maintenance would improve analgesia after elective cesarean delivery (CD).

NCT ID: NCT03321175 Completed - Clinical trials for Cesarean Section; Complications, Wound, Hematoma

Evaluation the Impact of Subcutaneous Irrigation on Wound Complications

Start date: October 23, 2017
Phase: N/A
Study type: Interventional

to evaluate the effect of subcutaneous irrigation on wound complications

NCT ID: NCT03298334 Recruiting - Obesity, Childhood Clinical Trials

Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates.

Start date: July 1, 2018
Phase: Phase 1/Phase 2
Study type: Interventional

Neonates delivered by scheduled Cesarean Section will be randomized to receive vaginal seeding (exposing the infant to Mother's vaginal flora) or sham. Infants will be followed for three years to examine health outcomes including microbiome development, immune development, metabolic outcomes, and any adverse events.

NCT ID: NCT03236324 Completed - Cesarean Delivery Clinical Trials

Transversalis Fascia Plane Blocks for Analgesia Post-cesarean Delivery

Start date: September 22, 2017
Phase: Phase 2
Study type: Interventional

The aim of this study is to assess the efficacy of a bilateral TFP block in parturients undergoing cesarean delivery (CD) by evaluating postoperative opioid consumption and numeric rated pain scores in two groups (TFP block with saline (control) and TFP block with local anesthetic (treatment)). Women (American Society of Anesthesiologists physical status Class 1-3) at term gestation with singleton pregnancies undergoing an elective CD under spinal anesthesia at the South Health Campus will be consented to participate in the study. Patients will be randomly assigned using a computer-generated table of random numbers to two groups. Group allocations will be concealed. All patients will receive spinal anesthesia with spinal Morphine according to our institutional protocol. At the end of surgery, randomized patients will receive either ultrasound-guided bilateral TFP blocks with 0.25% bupivacaine with 2.5 mcg/ml epinephrine 40 ml total or maximum 2.5 mg/kg (Group 1) or 40 mL saline (Group 2) by 2 anesthesiologists experienced in performing this block.

NCT ID: NCT03150641 Completed - Cesarean Delivery Clinical Trials

Delayed Cord Clamping at Term Cesarean

Start date: September 18, 2017
Phase: N/A
Study type: Interventional

The purpose of this research study is to find out how delaying cutting the umbilical cord until one minute after delivery of the baby during a cesarean impacts the amount of blood the mother loses during surgery. The study will also examine the benefits to the newborn from delayed cord clamping during cesarean.

NCT ID: NCT03136159 Completed - Clinical trials for Cesarean Section; Complications, Wound, Dehiscence

The Role of Antimicrobial Foam Dressing in Prevention of Cesarean Section Wound Complications

Start date: July 24, 2017
Phase: N/A
Study type: Interventional

Post-cesarean section wound infections are responsible for longer hospital stays, readmissions, and ultimately, increased costs to the healthcare system. Silver-containing dressings may prevent wound infections. The purpose of the current study is to determine if the use of a silver-impregnated dressing decreases the occurence of wound infection following cesarean delivery.

NCT ID: NCT03063853 Completed - Clinical trials for Cesarean Section; Wound, Infection (Following Delivery)

Removal of Surgical Staples After Cesarean Delivery. Randomized Control Trial.

ROCD
Start date: February 1, 2017
Phase: N/A
Study type: Interventional

The optimal choice of skin closure at cesarean delivery has not yet been determined. This study aim to study the wound complications and scar healing after Surgical staples removal at postoperative day 4 and day 8 . A randomized control trial.

NCT ID: NCT03039426 Completed - Cesarean Delivery Clinical Trials

Postoperative Cesarean Delivery Pain Relief; Diclofenac Versus Bupivacaine

Start date: January 1, 2017
Phase: Phase 4
Study type: Interventional

This randomized controlled trial, compared postoperative pain score in patient undergoing cesarean delivery between bupivacaine peritoneal and subcutaneous infiltration and diclofenac intramuscular injection

NCT ID: NCT03031353 Recruiting - Clinical trials for Cesarean Delivery Affecting Fetus

Misoprostol Before Elective Caesarean Section for Decreasing the Neonatal Respiratory Morbidity

Start date: January 2017
Phase: N/A
Study type: Interventional

Neonatal respiratory distress may occur in either term or preterm newborns with a higher relative risk in preterm, and whether born vaginally or through caesarean section, but in a higher percentage after elective caesarean section whose rate is rising. Prostaglandins may be given about one hour before an elective caesarean section after excluding the presence of contraindication to their use to decrease the neonatal respiratory diseases and thus, the number of children who suffered from bronchopulmonary dysplasia that occurs frequently in children who had previously TTN will diminish.

NCT ID: NCT03030742 Completed - Opioid Use Clinical Trials

Postpartum Opioid Prescribing Patterns and Patient Utilization

Start date: June 1, 2017
Phase:
Study type: Observational

This study seeks to investigate the prescribing patterns and patient utilization of opioid pain medication in the postpartum setting. Postpartum women will be surveyed prior to hospital discharge and again at 2-4 weeks postpartum in order to assess the number of opioid tablets they used (in relation to the number prescribed), pain satisfaction, and storage/disposal of any remaining opioid tablets.